Address

Other Office
3130 Highland Avenue
Suite 3205
Cincinnati, OH 45219
United States

Open map


Recent investment activity

KANDO id: 30306

Corporate information

Official name
Charter Life Sciences Limited Partnership
Registration country

Company type

Venture capital fund with a focus on clinical stage life sciences

Fund terms

Fund type

Funding rounds

Fund Closing USD 66,300,000


USD 66,300,000 ( )

Profile Country

Fund Closing USD 30,000,000


USD 30,000,000 ( )

Profile Country

Fund Closing USD 100,000,000


USD 100,000,000

Profile Country

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 12 of 12
Profile Country Date Funding
Asthmatx Inc Series D
CoMentis Inc N/A
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to N/A
Great Lakes Pharmaceuticals Inc Developer of an anti-infective lock solution to address in-dwelling venous catheter mediated infection. Series B
Intarcia Therapeutics Inc A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t N/A
Kereos Inc Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. N/A
KFx Medical Corp N/A
Mirabilis Medica Inc Developer of non-invasive ultrasound technology for the treatment of uterine fibroids N/A
Revascular Therapeutics Inc N/A
Xlumena Inc Xlumena is a medical device company. Series B
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. Series A Initial investment
Barrx Medical Inc Minimally invasive placed single use disposable medical device for the treatment of Barrett’s esophagus. N/A

Past employees

Selected Products / Customers

Financials